WeVote
Log In

Bill

Bill

HB 3455

Relating to manufacturer disclosure requirements and liability for experimental drugs and devices.

89th Legislature (2025) Introduced by Cody Harris and 11 co-sponsors

HB 3455 defines manufacturer disclosure rules and liability standards for experimental drugs and devices to clarify legal obligations in Texas medical innovation.

Withdrawn from schedule
#civilremedies&liabilities(i0065) #consumerprotection(i0080) #health--general(i0385) #medicine&prescriptiondrugs(s7338) #safety(i0740)
0
WeVote Research Nonpartisan
Bill Summary · HB 3455

Legislative bill overview

HB 3455 establishes manufacturer disclosure requirements and defines liability standards for experimental drugs and devices in Texas. The bill appears designed to clarify legal responsibilities and transparency obligations when manufacturers produce or distribute pharmaceuticals and medical devices that have not completed full regulatory approval or are in testing phases.

Why is this important

Experimental drugs and devices occupy a legal gray area—patients may benefit from cutting-edge treatments, but manufacturers' liability exposure and disclosure obligations are sometimes unclear. This bill would establish clearer rules for when and how manufacturers must inform patients, healthcare providers, and regulators about experimental status, potentially affecting access to innovative treatments, litigation outcomes, and patient safety protections in Texas.

Potential points of contention

  • Manufacturer liability limits: Provisions may attempt to restrict lawsuits against manufacturers for experimental treatments, which consumer advocates and trial lawyers would likely oppose, while manufacturers would support
  • Disclosure scope and timing: Disagreement over how much information must be disclosed, to whom, and at what stage of development—balancing transparency against protecting proprietary research
  • Patient access vs. safety: Tension between enabling faster access to potentially life-saving experimental therapies versus maintaining rigorous safety standards and informed consent protections

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.